In addition, LAMP3 overexpression was relevant to chemotherapy and radiotherapy resistance in breast cancer14 and knocking down LAMP3 may promote the sensitivity of patients to cisplatin in prostate cancer.15 Here, LAMP3 is linked to prostate carcinoma.